Correction: Suppression of PKC causes oncogenic stress for triggering apoptosis in cancer cells

Suthakar Ganapathy^1,*, Bo Peng^1,*, Ling Shen¹, Tianqi Yu¹, Jean Lafontant¹, Ping Li^2,3, Rui Xiong³, Alexandros Makriyannis¹ and Changyan Chen¹

¹Center for Drug Discovery, Northeastern University, Boston, MA, USA
²The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China
³The Institute of Clinic Sciences, Sahlgrenska Academy, Gothenburg, Sweden
^*These authors contributed equally to this work

Published: February 25, 2023

This article has been corrected: In Figure 3, the panel B image of MIA - MnSOD contains an accidental duplicate of the Figure 6, panel B image of MIA - GADD153. The corrected Figure 3B, produced using the original data, is shown below. The authors declare that these corrections do not change the results or conclusions of this paper.

Original article: Oncotarget. 2017; 8:30992–31002. DOI: https://doi.org/10.18632/oncotarget.16047

Figure 3: ROS regulators were activated after co-suppression of PKC α and β. (B) MnSOD expression in the cells after the treatments was analyzed by immunoblotting.